Hyperthermic Intraperitoneal Chemotherapy
Board Certified in Surgery
Moller continues to raise the level of treatment throughout the area. She has experience with many types of abdominal cancer, including peritoneal mesothelioma, a rare malignancy caused by the ingestion of asbestos fibers.
Doctors perform the HIPEC procedure immediately after cytoreductive surgery to remove all visible tumors.
They circulate a heated, high-dose chemotherapy solution throughout the abdominal cavity for 90 minutes. This is meant to kill any remaining microscopic cancer cells.
By keeping chemotherapy in the abdomen rather than injecting it in the bloodstream, doctors can increase the dosage without causing serious side effects. Heating the solution allows for better cell penetration.
“We are excited to be able to offer this cutting-edge technology for patients with advanced abdominal cancers,” Moller said. “Clinical studies show HIPEC to be significantly more effective than surgery or chemotherapy alone. We are able to offer patients an improved prognosis and quality of life.”
HIPEC is being used for colon, gastrointestinal tract and ovarian cancers. In centers where it is available, HIPEC has become almost standard in treatment of peritoneal mesothelioma.
Studies have shown a five-year survival rate of 50 percent for peritoneal mesothelioma patients who receive HIPEC.
Moller is the director of the HIPEC Peritoneal Malignancies Program at the University of Miami Miller School of Medicine. There, she also serves as an associate professor of surgery.
Her research interests include breast cancer and gastrointestinal malignancies. She has clinical interests in pancreatic tumors, gastrointestinal stroma tumors, appendiceal cancers, small bowel cancers, melanoma and mesothelioma.
She completed her fellowship in surgical oncology at the University of South Florida and the Moffitt Cancer Center in 2009. She did her residency in general surgery at Michigan State University.
Moller received her medical degree from Universidad Nacional Autonoma De Nicaragua-Leon in 1997.
Disclaimer: Dr. Mecker Moller has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers. Read More